Nakamoto / KindlyMD

Phase A — Understand the business

Lens 1 · Company Overview

Nakamoto Inc. (formerly KindlyMD) is a Bitcoin treasury and "Bitcoin operating company" — a publicly traded vehicle whose primary purpose is to hold Bitcoin on its balance sheet and give equity investors levered exposure to BTC, wrapped around a small operating ecosystem of Bitcoin-native media, asset management, and advisory businesses. "Nakamoto Inc., formerly known as KindlyMD, Inc., is … a Bitcoin operating company with media, asset management, and advisory capabilities, together with a bitcoin treasury … Nakamoto seeks to provide investors with exposure to Bitcoin's global growth".

The corporate origin story is itself the business model: the company "was formed in 2019 as a healthcare company and began its transformation into a Bitcoin operating company in August of 2025, with the merger between Nakamoto Holdings, Inc. and Kindly MD, Inc.". It re-domiciled from Utah to Delaware on 2025-12-27 and renamed to Nakamoto Inc. on 2026-01-21. In March 2026 management "announced our intention to exit this legacy [healthcare] business" — and by June 2026 had closed its last clinic, completing the pivot.

Four revenue lines (Q1 2026, in $000s):

• Derivative — $1,071 (the largest line): premium income from writing covered calls/spreads on BTC and selling protective-put structures.
• Advisory — $510: advising Bitcoin-native and adjacent companies on capital formation and transactions.
• Media — $409: Bitcoin Magazine + the Bitcoin Conference (via BTC Inc, acquired Feb 2026).
• Asset management — $209: management/performance fees from UTXO's funds (210k Capital et al.).
• Healthcare — $479 (legacy, being exited).
• Total operating revenue: $2,678 (vs $580 a year earlier — but the YoY growth is entirely M&A, not organic).

The "operating" businesses are real but tiny relative to the treasury: total revenue of ~$2.7M/quarter against a ~$345M digital-asset balance sheet. This is, functionally, a closed-end Bitcoin fund with a media/advisory garnish — the operating segments matter for the narrative (and as a differentiator vs. pure-play treasuries) far more than for the P&L.

Key counterparties / structure:

• Custody + lender: Kraken (via Payward Interactive) — both custodian-adjacent and the secured lender on the $210M (now $165M) loan.
• Promoter / controller: David Bailey, Chairman & CEO, founder of BTC Inc and co-founder of UTXO — the entire ecosystem is his.
• Contract structure: No take-or-pay or recurring-contract base. Revenue is (i) mark-to-market derivative premium (volatile), (ii) event-driven media (the Bitcoin Conference is seasonal — Q2/Q3 weighted), and (iii) AUM-based fees that rise and fall with BTC. There is no contracted backlog cushioning the downside.

Lens 2 · Supply Chain

A treasury company's "supply chain" is its capital-and-custody chain — where the money comes in, where the Bitcoin sits, and who can force a sale. Named stakeholders along that chain:

Upstream (capital in):

• PIPE Subscribers — accredited investors who funded ~$518M net at $1.12/share in the August 2025 reverse merger. One of the largest PIPEs in digital-asset history.
• Convertible debenture holders — a $200M secured convertible debenture ("96.0% of the Principal Amount") was issued and substantially repaid ($203M repayments, $191.85M net proceeds recorded).

Midstream (the company + its BTC):

• The treasury: 5,064 BTC at 2026-03-31 (5,342 at 2025-12-31), cost basis $598.9M, fair value $345.5M. By June 2026: ~4,467 BTC after a 600-BTC sale.
• Custodians: U.S.-based institutional-grade custodians; the bulk pledged to Kraken under the Master Loan Agreement.

The chokepoint — and it is acute: of 5,064 BTC, 4,405 were pledged as collateral to Kraken at 2026-03-31, leaving only 659 unencumbered Bitcoin (~$44.9M). The pledged BTC carries a contractual sale restriction (FV ~$300.5M) through the loan maturity of 2026-12-04. This is the single-source dependency: Kraken is simultaneously the lender, the collateral agent, and the venue for the option-writing wallet. A margin/collateral call from a BTC drawdown forces liquidation at the worst possible time — management lists this risk explicitly: "The risk that margin or collateral calls could require the forced liquidation of Bitcoin holdings at unfavorable prices".

Downstream (the "end customer"): the NAKA equity holder. The "product" delivered to them is BTC-per-share — and the chain leaks value at the equity wrapper (see Lens 7/11: the stock trades at ~0.33x the BTC it represents).

Lens 3 · Competitive Advantages (moats)

The honest answer: the moat is thin, and what moat exists is a promoter-brand moat, not a structural one.

• Scale moat — absent. At ~4,467 BTC, Nakamoto is a sub-scale treasury. Strategy (MSTR) holds ~845,256 BTC; Metaplanet ~35,000–40,000; Semler ~5,048. Nakamoto is roughly Semler-sized — a rounding error next to MSTR — so it has no cost-of-capital advantage and no index-inclusion gravity.
• The differentiator management leans on — an operating ecosystem. Unlike a pure-play treasury, Nakamoto owns BTC Inc (Bitcoin Magazine + the Bitcoin Conference, ~67,000 attendees across the 2025 series; the flagship US event drew 31,000+) and UTXO/210k Capital (a Bitcoin hedge fund that "since its inception … has outperformed Bitcoin on an annualized basis"). The thesis is that these throw off fee/event income and a media flywheel that a bare treasury cannot. This is a genuine point of differentiation — but at ~$1.1M/quarter of combined media+advisory+AM revenue, it is a narrative moat, not yet an earnings moat.
• Brand / promoter moat — real but double-edged. David Bailey is arguably the most recognizable promoter in Bitcoin (Bitcoin Conference founder, Trump's 2024 crypto-policy advisor, credited with influencing the US Strategic Bitcoin Reserve). That confers reach, deal flow, and a built-in audience. But promoter-brand moats are reflexive — they hold only while the stock works; once the equity trades at a deep discount, the brand becomes a liability (the very risk factor on "social media activity by our directors and officers" ).
• Bargaining power — weak. Over Kraken (its sole lender/custodian): weak — it needs the financing more than Kraken needs the loan, evidenced by the collateral top-ups (an extra 688 BTC pledged Feb 2026). Over the capital markets: at 0.33x mNAV, equity issuance is value-destructive, so its primary financing tool is broken (see Lens 11).

Verdict on the moat: there is no durable structural moat. The only defensible asset is the Bitcoin itself plus the BTC Inc media brand; everything else is promoter reflexivity. A skeptic should treat this as a leveraged BTC ETF with a charismatic management overlay and worse liquidity.

Lens 4 · Segments

The 10-K reports two principal segments as of 2025-12-31 — Bitcoin Operations and Healthcare Operations — but the Q1 2026 acquisitions added Media & Information Services and Asset Management reporting units (where the $93.5M of new goodwill landed).

Revenue by line, Q1 2026 vs Q1 2025 ($000s):

The number that dwarfs all segment revenue is not revenue at all — it is the $102.5M loss on change in fair value of digital assets in Q1 2026, "primarily reflecting the decline in price of Bitcoin … from $87,519 on December 31, 2025, to $68,220 on March 31, 2026". Plus a $107.7M loss on the related-party BTC Inc call option (a non-cash purchase-accounting artifact). Together these drove a $238.8M net loss for the quarter. Segment-level operating revenue is economically irrelevant next to the mark-to-market swing on the treasury — which is the whole point: for a treasury company, "segments" is a misdirection; the only segment that matters is "BTC price × coins held, minus financing cost."

Geography: not separately broken out in a meaningful way; media events span US/Asia/Europe/MENA but revenue concentration is not disclosed at the geographic level.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — Q1 2026, period ended 2026-03-31)

The Q1 2026 10-Q is the most recent print on the shelf. Headline:

• Total operating revenue: $2.68M (vs $0.58M Q1 2025) — but $0.48M of that is the dying healthcare line; the new ecosystem lines ($1.1M) were only ~5 weeks consolidated (BTC Inc/UTXO closed 2026-02-20).
• Operating loss: $(126.2)M — of which $102.5M is the BTC fair-value loss and $7.9M is a loss on investments (Metaplanet + Treasury B.V.). Cash operating overhead is visible in compensation $7.3M and G&A $9.8M — i.e., ~$17M/quarter of cash SG&A against ~$2.7M revenue.
• Net loss: $(238.8)M, or $(0.38)/share on 636.5M weighted avg shares. The incremental ~$112.6M of non-operating loss is dominated by the $107.7M related-party call-option remeasurement.
• Balance sheet: Cash $35.3M; digital assets $345.6M (cost $598.9M — a ~$253M embedded unrealized loss; they bought near the cycle top); notes payable $209.7M; total equity $367.1M; accumulated deficit ballooned from $60.0M to $298.8M in one quarter.
• Cash flow: operating cash burn $(23.3)M for the quarter; investing +$36.6M (funded by selling $20.7M of BTC and $11.1M of Metaplanet stock — i.e., liquidating assets to fund operations, the classic treasury-in-stress tell).
• Guidance: none given (no guidance.csv rows; the company does not guide). Management asserts liquidity sufficiency for 12 months but explicitly conditions it on BTC price.

Unusual vs. its own history: the $238.8M net loss is ~230x the prior-year quarter's $1.0M loss — but it is almost entirely non-cash mark-to-market and purchase accounting, not operational deterioration. The economically meaningful negatives are (1) the $253M underwater cost basis, (2) ~$17M/quarter cash SG&A with negligible revenue, and (3) the asset sales to fund the burn.

Market reaction: the stock is down ~99.5% from its ~$29 May-2025 high and required a 1-for-40 reverse split (effective 2026-05-22) to hold its Nasdaq listing. The tape's verdict on this print and trajectory is unambiguous and brutal.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf (transcripts=0); Nakamoto is a recently-public micro-cap and does not run a conventional quarterly call cadence. The closest proxy is its press-release / 8-K sequence, where the tonal shift is legible:

• May 2025 (merger announcement): maximal ambition — "$710 million raised," "one of the largest PIPE financings in digital asset history," building a "global portfolio of Bitcoin-native companies". Promoter-confident.
• Feb 2026 (BTC Inc / UTXO close): empire-building narrative — media + asset management bolted on, "all-stock Bitcoin empire deal".
• May–June 2026 (reverse split + debt refinance + buyback): the language flips to survival and repair — "strengthening capital structure through debt reduction," "regained compliance with Nasdaq's minimum bid price," authorizing a buyback "as part of its capital allocation strategy". The June 11 framing emphasizes cutting financing cost by ~$4M/year and trimming debt — a defensive posture, not an accumulation one.

The arc — from "largest PIPE in history / building an empire" to "refinancing to survive and buying back stock at a 67% discount" in under 12 months — is the single most important sentiment signal in the file. Management stopped talking about accumulating BTC and started talking about reducing debt and narrowing the discount.

Lens 7 · Comps

Bitcoin treasury companies are valued on mNAV (market cap ÷ BTC net asset value), not P/E — they have no earnings to speak of. The peer set and the punchline:

Standard equity multiples are n/a and not meaningful (the company is loss-making with no consensus EPS line; P/E, EV/EBIT, dividend yield, 5-yr avg ROE all n/a for a 10-month-old treasury entity).

The comp that matters: Nakamoto trades at ~0.33x the value of its own Bitcoin — roughly a 67% discount to NAV (~$280M of BTC vs ~$76M market cap as of 2026-06-11). That is well below Semler (0.88x) and a different planet from Metaplanet (1.37x). The entire investment debate collapses into one question: does that 0.33x converge toward 1x, stay there as a permanent "promoter-discount + financing-overhang" haircut, or go to zero in a forced unwind?

Lens 8 · Stock-Price Catalysts

NAKA has only ~13 months of trading history, but the >5% moves cluster tightly around treasury/capital-structure events, not "fundamentals":

• May 2025 — merger reveal: spike to ~$29 high on the KindlyMD↔Nakamoto reverse-merger + $710M PIPE news.
• Aug 2025 → 2026 — secular grind down ~99.5%: dilution overhang from 343M PIPE shares at $1.12, BTC's drawdown from ~$87.5k to ~$68k, and a widening discount-to-NAV.
• 2026-05-22 — 1-for-40 reverse split (696.1M → ~17.4M shares) to cure the sub-$1 bid; 2026-06-09 — Nasdaq compliance regained.
• 2026-06-11 — +20% intraday on the 600-BTC sale / Kraken refinance / $25M buyback package.

Pattern: the market reacts to (a) BTC price, (b) dilution/capital-structure events, and (c) discount-narrowing signals (buybacks, debt paydown). It does not react to operating-segment revenue. The +20% pop on a Bitcoin sale is the tell — for a stock at 0.33x mNAV, selling BTC to cut debt and buy back stock is NAV-accretive per share, so the market cheered shrinkage. That is the playbook the bull case depends on, and the bear case says it is too small and too late.

---

Phase C — Judge people & books

Lens 9 · Management

• David Bailey — Chairman & CEO, age 35. Co-founder/CEO of BTC Inc (2015–Nov 2025), General Partner at UTXO (2019–2026), board roles at the Bitcoin Policy Institute, Moon Inc, RTB Digital; BA in Finance & Entrepreneurship, University of Alabama Honors College. Track record: built the most important Bitcoin media franchise (Bitcoin Magazine + the Conference) and a respected crypto hedge fund (210k Capital, which has reportedly outperformed BTC) — a genuine builder in the space, and a Trump 2024 crypto-policy advisor credited with shaping the US Strategic Bitcoin Reserve. The flip side: he is a promoter first — his comparative advantage is narrative, reach, and capital-raising, not operating discipline or capital allocation under stress. He took the company public via reverse merger and raised one of the largest digital-asset PIPEs ever — then watched the equity fall ~99.5%.
• Teresa Gendron — CFO (since Dec 2025), age 56. Ex-CFO of Jefferies Financial Group (2014–2023) — a serious, credible public-company finance hire. Her arrival (plus a Chief Accounting Officer, Brian Dalton, also ex-Jefferies) is the most reassuring fact in the management section: adult financial supervision was brought in after the material weaknesses surfaced.
• Tyler Evans — CIO, age 34 — co-founder of BTC Inc and UTXO; runs the investment side; added to the board (Class II) in May 2026.
• Tim Pickett — founder/CMO (was CEO of the legacy KindlyMD since 2019) — being de-emphasized as healthcare is exited.

Skin in the game: Bailey and Evans received large equity stakes via the BTC Inc/UTXO all-stock acquisitions, so ownership is meaningful — but no insider-transactions.csv is on the shelf to quantify precise % or recent open-market buys/sells. n/a at the share level.

Capital-allocation history (the part that matters): the record so far is poor on timing — they deployed PIPE proceeds into BTC near the cycle top (cost basis $598.9M vs $345.5M FV = ~$253M underwater). The partial correction is the June 2026 pivot: selling BTC to cut debt and buy back deeply-discounted stock — which, at 0.33x mNAV, is the right allocation move (NAV-accretive), and a sign the new CFO is steering toward per-share value rather than maximalist accumulation.

Red flags (management-specific):

1. Related-party density. Bailey and Evans sat on both sides of the BTC Inc and UTXO acquisitions ("Bailey … and Tyler Evans … are also a director … chief executive officer and chief investment officer of BTC Inc"). The $128.6M BTC Inc valuation and $52.8M UTXO valuation were set by an independent third-party specialist, but these were insider-to-company asset transfers funded with NAKA stock — a structural conflict, even if procedurally papered.
2. "Limited public company experience" is a named risk factor for the senior team — partially mitigated by the Jefferies finance hires.
3. Social-media / promotional risk is explicitly risk-factored — unusual, and a tell about the CEO's public profile.

Archetype: founder-promoter, not operator. For a treasury vehicle in accumulation/bull phase that archetype is an asset (he can raise and narrate); in repair/discount phase it is a liability (the skills that built the discount are not the skills that close it). The Gendron hire is the hedge.

Lens 10 · Forensic Red Flags

Acting as a forensic analyst. The accounting is, by treasury-company standards, clean in disclosure but structurally fragile, and there is a flashing-amber control issue.

• Material weakness in internal control over financial reporting — confirmed and current. Management concluded disclosure controls "were not effective as of December 31, 2025" and reaffirmed the same as of March 31, 2026. Three named weaknesses: (1) segregation of duties (journal-entry prep/review/approval), (2) insufficient accounting/finance resources, (3) lack of formalized policies and risk assessment. Remediation is in progress (the CFO/CAO hires) but explicitly not yet remediated. For a company whose balance sheet is dominated by Level 1 (BTC) and Level 3 (call options, intangibles) fair-value marks, a controls weakness over journal entries and fair-value processes is non-trivial.
• Embedded unrealized loss / cost-basis overhang. $598.9M cost vs $345.5M FV on BTC. Under fair-value accounting this is already in the P&L (not hidden), but it means the treasury must rally ~73% just to get the Bitcoin back to cost — separate from the equity discount.
• Purchase-accounting noise. The $107.7M related-party call-option fair-value loss and $93.5M of goodwill (Media $70.8M + AM $22.7M) plus $69.3M of intangibles (mostly $68.4M "trade names," 10-yr life) are Level 3, preliminary, and subject to revision. Goodwill + indefinite-lived domain name ($3.0M) are impairment candidates if the media/AM businesses underperform — a future non-cash hit risk. None impaired as of Q1 2026.
• Cash flow vs. earnings divergence — benign here. The $238.8M net loss vs $(23.3)M operating cash burn gap is fully explained by non-cash marks (BTC FV, call-option FV, SBC) — not a receivables/inventory red flag. Receivables/inventory are immaterial (this is a treasury, not an operating business). The real cash story is the $23.3M/quarter burn funded by asset sales, which is a liquidity flag, not an accounting one.
• Going-concern: management asserts 12-month sufficiency but conditions it explicitly on BTC price and flags forced-liquidation risk. Not a formal going-concern qualification, but the conditionality is doing a lot of work.

Regulatory findings (required sub-section):

• SEC Litigation Releases / AAERs: 0 found. "No LR found … No AAER found for this company in the search period" (2021-06-24 → 2026-06-24).
• Item 1/Item 3 Legal Proceedings: the 10-Q discloses only ordinary-course litigation — "commercial disputes, intellectual property matters, and employment related matters" — and states "none of our pending lawsuits … are expected to have a material adverse effect". The 10-K notes potential legacy "tail" liabilities from the healthcare business (medical malpractice, HIPAA, FCA/qui-tam exposure) as a risk, not an active matter.
• Non-SEC enforcement (web): no material FTC/DOJ/FDA/CFPB action against Nakamoto/KindlyMD surfaced. (Note: the 10-K cites the NY AG's civil-fraud suit against Genesis/DCG as industry context, not as a Nakamoto matter.)
• Net: No material regulatory or legal findings against the company — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K/10-Q legal-proceedings disclosure as of 2026-06-24. The forensic risk is the ICFR material weakness, not litigation.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

EPS projection is the wrong tool here — Nakamoto has no normalized earnings; its "value" is BTC-per-share net of debt. So the projection is a NAV-bridge, with EPS noted as not meaningful.

The valuation identity (all, inputs labeled):

• BTC NAV ≈ 4,467 BTC × BTC price. At ~$63k BTC ≈ $281M; less $165M net debt (post-June refinance) less small other = **$116–120M net asset value **.
• Market cap ≈ $76–86M.
• Implied **equity-level mNAV on net-of-debt NAV ≈ 0.65–0.75x **; on gross BTC NAV ≈ 0.33x. (The two framings differ because of the ~$165M debt — leverage is why the gross discount looks deeper than the net.)

Three paths (12–18 months):

• Base (~50%): discount persists in the 0.4–0.7x (net) band; buyback ($25M auth., ~⅓ of the market cap) is NAV-accretive but too small to fully close the gap; BTC roughly flat. Equity drifts with BTC ± buyback support. Outcome: range-bound, high-variance, no structural re-rating.
• Bull (~25%): BTC rallies + the buyback/debt-paydown flywheel + media/AM revenue scaling demonstrates the "operating company ≠ pure treasury" thesis; discount narrows toward Semler-like ~0.85x. With ~$116M net NAV, closing to 0.85x net ≈ ~$100M cap ≈ +20–60% from here, amplified by BTC upside (leverage cuts both ways). Outcome: multi-bagger only if discount-close and BTC both cooperate.
• Bear (~25%): BTC drawdown triggers a Kraken collateral call against the 4,400-BTC pledge → forced sale at the bottom → the $253M cost-basis hole crystallizes in cash terms → equity dilution or distress; the Dec-4-2026 ($60M tranche) and June-30-2027 ($105M tranche) maturities become refinancing cliffs at a sub-1x equity that cannot issue accretively. Outcome: 50–100% impairment of the equity; the discount goes to zero the hard way.

Brier forecast — not logged (per --watchlist rule: no forecast.ts create in the breadth loop). The natural binary to track if promoted: "NAKA equity-level mNAV (net of debt) ≥ 0.85x by 2027-06-30," p ≈ 0.25.

Lens 12 · Bull vs Bear

Bull case. You are buying ~$1 of Bitcoin (plus a real media brand and a hedge fund) for 33–65 cents, run by the most networked promoter in the asset class, who has just pivoted to the correct value-accretive playbook: sell pledged BTC, cut the 8%-ish Kraken debt ($4M/yr saved), and buy back stock while it trades below NAV — every dollar of buyback below 1x mNAV mechanically increases BTC-per-share for remaining holders. If BTC resumes its secular climb and the discount even partially normalizes toward the Semler/peer band, the equity is a levered double on two independent tailwinds. The optionality of the BTC Inc media flywheel (67k conference attendees, the genre-defining magazine) and UTXO's outperforming fund is free at this price — the market is valuing them at less than zero. Contrarian read: the market is treating a discounted, de-levering, brand-rich treasury as if it were a zero, when management has already started doing the one thing that closes the gap.

Bear case (2–3 permanent-impairment risks).

1. The discount is rational, not a mispricing. A 0.33x gross mNAV reflects (i) ~$165M of senior secured debt ahead of equity, (ii) a forced-seller dynamic (Kraken can liquidate the collateral), (iii) ~$17M/quarter cash SG&A bleeding NAV, and (iv) a promoter whose timing was demonstrably bad. Discounts on sub-scale, levered, cash-burning treasuries can persist indefinitely or widen — there is no mechanism that forces convergence to 1x.
2. Financing reflexivity / maturity wall. With equity below NAV, the company cannot issue stock accretively — its primary growth and refinancing tool is disabled. The $60M (Dec 2026) and $105M (June 2027) USDT tranches must be repaid or refinanced; if BTC is weak into those dates, the only levers are more BTC sales (shrinking the asset) or distressed dilution.
3. Forced liquidation in a drawdown. 4,405+ BTC are pledged; a sharp BTC fall triggers collateral calls and forced sales "at unfavorable prices" — the exact scenario that converts a paper cost-basis loss into permanent capital destruction and can cascade into insolvency.

Pre-mortem (18 months out, thesis broke): BTC fell 30–40% in H2 2026; Kraken collateral calls forced Nakamoto to dump pledged BTC near the lows; the $60M December tranche couldn't be refinanced on workable terms; the company issued equity at a deeper discount (or sold the rest of the treasury), the buyback was abandoned, BTC Inc/UTXO goodwill was impaired, and the equity rerated from "discounted treasury" to "melting ice cube." The promoter's social-media presence amplified the unwind.

Are multiples too high? No — multiples are low (0.33x). The bear thesis is not "overvalued"; it is "cheap for cause, and the cause can compound to zero." This is a deep-value / distressed setup, not a growth-multiple short.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case. The "buy $1 of BTC for 33 cents" pitch ignores that you do not own the BTC — the senior lender has first claim on 4,400+ of the 4,467 coins. Equity is the residual behind $165M of secured debt on an asset that whipsaws 20% a quarter; the "discount" is the market correctly pricing subordination + forced-seller risk + cash burn. Revenue is concentrated in mark-to-market derivative premium and a seasonal conference — neither is durable, and the option-writing strategy caps the upside on the very BTC that is the whole thesis (written calls on 1,850 BTC at $83k–$100k strikes) while the puts only partially cover the downside. The most dangerous competitor bulls underrate is the spot Bitcoin ETF (IBIT et al.) — it offers clean, liquid, unlevered, no-promoter-risk BTC exposure at a few bps; why would the marginal buyer take Nakamoto's debt, dilution, governance, and material-weakness risk for the same underlying? The worst capital-allocation move is already on the books: buying BTC at a $598.9M cost basis now worth $345.5M, an instant ~42% loss of deployed capital, compounded by related-party acquisitions where the CEO/CIO sat on both sides. For today's ~$76M cap to make sense, you must assume the discount closes — but if growth/BTC disappoints by 20–30%, the leverage works in reverse and the equity is impaired 50–100% while the lender is made whole first. The single scenario that permanently impairs the business — a BTC drawdown forcing collateral liquidation into the Dec-2026 maturity — is not a tail; it is a plausible base-rate event for a levered crypto vehicle, and management has only ~659 unencumbered BTC and $35M cash to defend against it.

Lens 14 · Management Questions (ordered by information value)

1. At today's ~0.33x gross / ~0.65x net mNAV, what is your explicit framework for choosing between buying back stock vs buying more BTC vs paying down the Kraken debt — and at what mNAV does each become the priority?
2. Walk us through the Kraken collateral mechanics: at what BTC price do you face a maintenance/margin call on the 4,400+ pledged coins, and what is your defense plan if BTC falls 30% before the December 2026 tranche?
3. How do you refinance or repay the $60M (Dec 2026) and $105M (June 2027) USDT tranches if your equity is still below NAV and you cannot issue accretively?
4. What is your monthly cash burn post-healthcare-exit, and at what BTC price does the ~659 unencumbered BTC + cash run out before the next financing?
5. When will the material weakness in internal controls be fully remediated, and what testing will you publish to evidence it?
6. The BTC Inc and UTXO acquisitions were related-party transactions you sat on both sides of — what independent-committee process governed the $128.6M / $52.8M valuations, and would you do the deal structure the same way again?
7. What is the standalone, organic revenue and EBITDA trajectory of BTC Inc (media/events) and UTXO (AUM/fees) — excluding treasury marks — over the next 8 quarters?
8. Your option-writing program caps BTC upside via written calls; how do you reconcile that with a thesis premised on BTC appreciation?
9. What is the realistic path to index inclusion or scale that would compress the discount, given you are ~1/180th the size of Strategy?
10. Under what circumstances would you wind down the treasury and return capital (or sell the company) rather than persist at a discount?
11. What is current insider ownership and have you (Bailey/Evans) bought or sold NAKA in the open market since the reverse split?
12. What impairment triggers would force a write-down of the $93.5M goodwill / $69.3M intangibles, and what is your sensitivity?
13. How dependent is the financing relationship on Kraken specifically, and what is your contingency if Kraken changes terms or exits the relationship?
14. What are the residual legacy healthcare "tail" liabilities (malpractice, HIPAA, FCA), and are any reserved?
15. What does success look like in 24 months — a specific BTC-per-share target and the mNAV at which you'd consider the strategy validated?

---